So excited to see this out! Congratulations to @sarahehancock.bsky.social and everyone involved!
Ying Fei Liew
I'm so relieved to finally get this one up as a preprint. We started this project back in 2019 when we created our first gemcitabine (GEMC) resistant (GEMR) #PDAC cell line. We showed that GEMR upregulates lipid synthesis and that targeting different steps could sensitise cells to GEMC. 1/n 🧪👩🔬
Sarah E Hancock
Targeting de novo lipogenesis improves gemcitabine efficacy in pancreatic ductal adenocarcinoma https://www.biorxiv.org/content/10.1101/2024.12.18.628624v1
